IRUS Total

ICEC0942, an orally bioavailable selective inhibitor of CDK7 for breast cancer

File Description SizeFormat 
10.1007_s10549-016-3898-5.pdfPublished version320.46 kBAdobe PDFView/Open
Title: ICEC0942, an orally bioavailable selective inhibitor of CDK7 for breast cancer
Authors: Ali, S
Patel, H
Periyasamy, M
Bondke, A
Slafer, BW
Ottaviani, S
Harrod, A
Buluwela, L
Fuchter, MJ
Barrett, AGM
Coombes, RC
Item Type: Conference Paper
Issue Date: 20-Aug-2016
Date of Acceptance: 22-Jul-2016
URI: http://hdl.handle.net/10044/1/64205
DOI: https://dx.doi.org/10.1007/s10549-016-3898-5
ISSN: 0167-6806
Publisher: Springer Verlag
Start Page: 195
End Page: 195
Journal / Book Title: Breast Cancer Research and Treatment
Volume: 159
Issue: 1
Copyright Statement: © The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Sponsor/Funder: Cancer Research UK
Funder's Grant Number: C37/A9335
Conference Name: UK Breast Cancer Research Symposium
Keywords: Science & Technology
Life Sciences & Biomedicine
1112 Oncology And Carcinogenesis
Oncology & Carcinogenesis
Publication Status: Published
Start Date: 2016-07-22
Finish Date: 2016-07-23
Conference Place: London, ENGLAND
Appears in Collections:Department of Surgery and Cancer
Faculty of Natural Sciences